These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
507 related items for PubMed ID: 18661410
1. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis. Demircin G, Oner A, Erdoğan O, Delibaş A, Baysun S, Bülbül M, Bek K, Oksal A. Ren Fail; 2008; 30(6):603-9. PubMed ID: 18661410 [Abstract] [Full Text] [Related]
2. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ]. Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S. Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309 [Abstract] [Full Text] [Related]
3. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC. Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783 [Abstract] [Full Text] [Related]
4. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R. Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207 [Abstract] [Full Text] [Related]
5. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis. Yee CS, Gordon C, Dostal C, Petera P, Dadoniene J, Griffiths B, Rozman B, Isenberg DA, Sturfelt G, Nived O, Turney JH, Venalis A, Adu D, Smolen JS, Emery P. Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482 [Abstract] [Full Text] [Related]
11. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study. Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB. Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581 [Abstract] [Full Text] [Related]
12. Prognostic factors of diffuse proliferative lupus nephritis. Lim CS, Chin HJ, Jung YC, Kim YS, Ahn C, Han JS, Kim S, Lee JS. Clin Nephrol; 1999 Sep; 52(3):139-47. PubMed ID: 10499308 [Abstract] [Full Text] [Related]
13. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis. Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN. Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851 [Abstract] [Full Text] [Related]
14. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis. Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus. Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070 [Abstract] [Full Text] [Related]
15. Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens. Mok CC, Ho CT, Siu YP, Chan KW, Kwan TH, Lau CS, Wong RW, Au TC. Am J Kidney Dis; 2001 Aug; 38(2):256-64. PubMed ID: 11479150 [Abstract] [Full Text] [Related]
16. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C. Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309 [Abstract] [Full Text] [Related]